HAPLN1
Basic information
Region (hg38): 5:83637805-83720855
Previous symbols: [ "CRTL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HAPLN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in HAPLN1
This is a list of pathogenic ClinVar variants found in the HAPLN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-83641554-C-G | not specified | Uncertain significance (May 21, 2024) | ||
5-83641563-C-G | not specified | Uncertain significance (Jun 01, 2023) | ||
5-83641579-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
5-83641742-A-C | not specified | Uncertain significance (Apr 17, 2023) | ||
5-83641758-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
5-83644413-T-G | not specified | Uncertain significance (Mar 25, 2024) | ||
5-83644444-C-T | not specified | Uncertain significance (Oct 20, 2024) | ||
5-83644550-G-A | Likely benign (Apr 01, 2022) | |||
5-83644566-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
5-83644582-C-A | not specified | Uncertain significance (May 13, 2024) | ||
5-83644586-C-G | not specified | Uncertain significance (Dec 10, 2024) | ||
5-83644632-C-A | not specified | Uncertain significance (Dec 13, 2022) | ||
5-83644633-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
5-83644645-G-C | not specified | Uncertain significance (Sep 10, 2024) | ||
5-83652474-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
5-83652584-A-G | not specified | Uncertain significance (Oct 29, 2024) | ||
5-83652606-C-T | not specified | Uncertain significance (Aug 01, 2022) | ||
5-83652722-G-A | not specified | Uncertain significance (Nov 21, 2024) | ||
5-83652755-A-G | not specified | Uncertain significance (Jun 08, 2022) | ||
5-83652759-T-G | not specified | Uncertain significance (Mar 30, 2024) | ||
5-83673439-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
5-83673454-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
5-83673462-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
5-83673490-T-C | not specified | Likely benign (Aug 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HAPLN1 | protein_coding | protein_coding | ENST00000274341 | 4 | 83809 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.602 | 0.397 | 125729 | 0 | 7 | 125736 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.414 | 182 | 198 | 0.917 | 0.0000112 | 2294 |
Missense in Polyphen | 63 | 85.288 | 0.73867 | 857 | ||
Synonymous | -1.06 | 90 | 78.1 | 1.15 | 0.00000454 | 692 |
Loss of Function | 3.00 | 3 | 15.9 | 0.189 | 9.02e-7 | 172 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000549 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000549 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000190 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.;
- Pathway
- Extracellular matrix organization;ECM proteoglycans
(Consensus)
Recessive Scores
- pRec
- 0.185
Intolerance Scores
- loftool
- 0.341
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- Y
- hipred_score
- 0.699
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.946
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hapln1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; skeleton phenotype; growth/size/body region phenotype; craniofacial phenotype;
Zebrafish Information Network
- Gene name
- hapln1b
- Affected structure
- dorsal longitudinal anastomotic vessel
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- skeletal system development;cell adhesion;central nervous system development;extracellular matrix organization
- Cellular component
- extracellular region;extracellular matrix;synapse;collagen-containing extracellular matrix
- Molecular function
- hyaluronic acid binding;extracellular matrix structural constituent conferring compression resistance